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The cytolytic activity of natural killer (NK) cells is regu-
lated by inhibitory receptors that detect the absence
of self molecules on target cells. Structural studies of
missing self recognition have focused on NK recep-
tors that bind MHC. However, NK cells also possess
inhibitory receptors specific for non-MHC ligands,
notably cadherins, which are downregulated inmeta-
static tumors. We determined the structure of killer
cell lectin-like receptor G1 (KLRG1) in complex with
E-cadherin. KLRG1 mediates missing self recogni-
tion by binding to a highly conserved site on classical
cadherins, enabling it to monitor expression of
several cadherins (E-, N-, and R-) on target cells.
This site overlaps the site responsible for cell-cell
adhesion but is distinct from the integrinaEb7 binding
site. We propose that E-cadherin may coengage
KLRG1 and aEb7 and that KLRG1 overcomes its
exceptionally weak affinity for cadherins through
multipoint attachment to target cells, resulting in
inhibitory signaling.
INTRODUCTION
Natural killer (NK) cells are an essential component of innate
immunity against tumors and virally infected cells (Yokoyama
and Plougastel, 2003; Lanier, 2005; Bryceson and Long, 2008).
The cytolytic activity of NK cells is triggered by the ligation of
various activating receptors, each of which recognizes a different
molecule on the surface of target cells. Activating receptors
include natural killer group 2D (NKG2D) and DNAX accessory
molecule 1 (DNAM-1), which recognize MHC class I chain-
related gene A (MICA) or MICB and CD155, respectively. Inhibi-
tory receptors recognize molecules that are expressed on
normal cells as a means of protecting them from lysis by NK
cells. Classically, inhibitory receptors recognize MHC class I
(MHC-I) molecules and include members of the Ly49 and paired
immunoglobulin (Ig)-linked receptor (PIR) families in rodents and
of the killer Ig-like receptor (KIR) and leukocyte Ig-like receptor
(LILR) families in human (Deng and Mariuzza, 2006). Downregu-lation of surface MHC-I molecules, which is often a hallmark of
infectious or tumorigenic processes, results in loss of inhibition
of NK cell activation. In this way, cells with abnormal MHC-I
expression become targets of NK lytic activity (‘‘missing self’’
recognition) (Yokoyama and Plougastel, 2003; Lanier, 2005;
Bryceson and Long, 2008).
Although NK cell function is clearly regulated by MHC-I mole-
cules on target cells, recent studies have revealed that NK cells
also possess inhibitory receptors specific for non-MHC ligands
(Bryceson and Long, 2008). By mediating NK cell inhibition
through MHC-independent signaling, these receptors broaden
the missing self hypothesis to comprise molecules besides
MHC. Thus, the natural killer receptor protein 1 (NKRP-1) family
of C-type lectin-like NK receptors includes inhibitory receptors
that bind to lectin-like ligands: C-type lectin-related b (Clrb)
molecules in mice (Iizuka et al., 2003; Carlyle et al., 2004) and
the related lectin-like transcript 1 (LLT1) molecule in humans
(Aldemir et al., 2005; Rosen et al., 2005). Leukocyte-associated
Ig-like receptor 1 (LAIR-1) recognizes collagen as its biological
ligand (Lebbink et al., 2006).
Killer cell lectin-like receptor G1 (KLRG1) is a C-type lectin-like
inhibitory receptor that contains an immune receptor tyrosine-
based inhibitory motif (ITIM) motif (Guthman et al., 1995; Hanke
et al., 1998). In humans, KLRG1 is expressed by NK cells (50%–
80%) and by CD4+ (20%) and CD8+ (40%) ab T cells that
exhibit an effector or effector-memory phenotype (Voehringer
et al., 2001). In mice, KLRG1 is expressed by 30% of NK cells
and 10% of ab T cells. Infection with viruses or parasites leads
to substantial increases in KLRG1 expression (Voehringer et al.,
2001; Robbins et al., 2003; Thimme et al., 2005; Ibegbu et al.,
2005). The inhibitory function of KLRG1, its predominant expres-
sion on effector cells, and its induction during infections, together
suggest that KLGR1 raises the activation threshold of NK and
T cells, thereby attenuating effector responses and preventing
autoreactivity (Bryceson and Long, 2008; Colonna, 2006).
Recently, the biological ligand for KLRG1 was identified as
E-cadherin (Ito et al., 2006; Gru¨ndemann et al., 2006; Tessmer
et al., 2007). Cadherins comprise a family of transmembrane
proteins that mediate Ca2+-dependent cell-cell adhesion by ho-
motypic interactions (Pokutta and Weis, 2007; Gumbiner, 2005).
E-cadherin, whose extracellular region comprises five Ig-like
domains (EC1–EC5), is localized at the basolateral membrane
of epithelial cells where it establishes tight binding betweenImmunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc. 35
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NK Cell Receptor KLRG1 Bound to E-Cadherinneighboring cells in adherens junctions (Gumbiner, 2005).
Besides E-cadherin, KLRG1 recognizes N- and R-cadherins
(Ito et al., 2006), which are present in analogous structures in
other cell types.
The binding of E-cadherin to KLRG1 prevents lysis of E-cad-
herin-expressing target cells by KLRG1+ NK cells (Ito et al.,
2006). Moreover, KLRG1-cadherin interactions inhibit antigen-
induced proliferation of CD8+ T cells and their acquisition of
effector functions (Gru¨ndemann et al., 2006; Tessmer et al.,
2007). These results indicate that KLRG1 may prevent cytotoxic
cells from damaging tissues expressing E-, N-, or R-cadherins
(Colonna, 2006; Bryceson and Long, 2008). They also suggest
a role for KLRG1 in tumor immunosurveillance analogous to
missing self recognition by inhibitory NK receptors that bind
MHC-I (Ly49s and KIRs) (Colonna, 2006; Schwartzkopff et al.,
2007). The malignancy of epithelial tumors is often associated
with downregulation of E-cadherin, which renders tumor cells
invasive and metastatic (Takeichi, 1993; Cowin et al., 2005;
Jeanes et al., 2008). The KLRG1-E-cadherin system may serve
to detect potentially metastatic epithelial tumors with abnormal
cadherin expression (Colonna, 2006; Bryceson and Long, 2008).
So far, structural studies of missing self recognition have
focused on NK receptors that recognize MHC-I molecules
(Deng and Mariuzza, 2006). Structures of Ly49-MHC-I
complexes showed that Ly49s engage MHC-I at a site beneath
the peptide-binding platform (Dam et al., 2003; Held and Mar-
iuzza, 2008). By contrast, KIRs contact MHC-I through the
a1 and a2 helices and the bound peptide (Boyington et al.,
2000; Fan et al., 2001). We recently determined the structure of
the Ig-like NK receptor 2B4 (CD244) bound to CD48 that repre-
sents a multifunctional receptor-ligand system mediating both
activating and inhibitory effects (Velikovsky et al., 2007). To
understand MHC-independent missing self recognition by an
exclusively inhibitory NK receptor that recognizes a ligand
whose downregulation is associated with tumor progression,
we determined the structures of human and mouse KLRG1
bound to human E-cadherin and of mouse KLRG1 in unbound
form. The KLRG1-E-cadherin complexes revealed the nature
and location of the KLRG1 binding site on E-cadherin relative
to the sites that mediate E-cadherin interactions with itself and
with the heterotypic ligand aEb7 integrin. Collectively, these inter-
actions contribute to regulating the complex interplay between
cytotoxic lymphocytes and epithelial cells that occurs under
inflammatory and neoplastic conditions.
RESULTS
Interaction of KLRG1 with Cadherins
We used surface plasmon resonance (SPR) to demonstrate
specific binding of KLRG1 to E-cadherin. To permit directional
coupling to streptavidin-coated biosensor surfaces, peptide tags
containing biotinylation sequences were added to the N terminus
of KLRG1. Affinities were measured by flowing one- or two-
domain constructs (EC1 or EC1–EC2) of human or mouse
E-cadherin over surfaces immobilized with human or mouse
KLRG1 (Figure S1 available online). Equilibrium binding
constants (KDs) are presented in Table 1. In all cases, KDs in
range of 100–200 mM were obtained, irrespective of whether
EC1 or EC1–EC2 was used and of the presence or absence of36 Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc.Ca2+, which is required for homotypic cadherin interactions
(Pokutta and Weis, 2007). Previously characterized NK cell
receptor-ligand pairs, including Ly49-MHC-I, KIR-MHC-I
NKG2D-MICA, and 2B4-CD48 (Boyington et al., 2000; Deng
et al., 2008; Lengyel et al., 2007; Velikovsky et al., 2007), have
10- to 100-fold stronger affinities than observed here for
KLRG1 and E-cadherin.
The ability of mKLRG1 to bind both mouse EC1 (mEC1; KD =
160 mM) and human EC1 (hEC1; 130 mM) is consistent with the
finding that human E-cadherin is a xenogenic ligand for mouse
KLRG1 (mKLRG1) (Table 1; Ito et al., 2006). Because human
KLRG1 (hKLRG1) exhibits similar affinities for hEC1 and hEC1-
EC2 (200 mM and 100 mM, respectively) as does mKLRG1 for
mEC1 and mEC1-EC2 (160 mM and 120 mM, respectively),
KLRG1 mainly recognizes the N-terminal Ig-like domain of
E-cadherin. We also found that the affinity of mKLRG1 for N-cad-
herin, another classical cadherin identified as a KLRG1 ligand
(Ito et al., 2006; Tessmer et al., 2007), is effectively indistinguish-
able from that for E-cadherin (Table 1). No binding was detected
to P-cadherin, which is not a KLRG1 ligand (Ito et al., 2006).
Together, these results suggest that KLRG1 binds to a site that
is structurally conserved in several classical cadherins, as well
as in cadherins from different species.
Structure of KLRG1
KLRG1 is a type II transmembrane glycoprotein composed of
a C-type lectin-like domain (CTLD) connected by a stalk region
of 19 residues to a transmembrane segment and cytoplasmic
domain (Guthman et al., 1995; Hanke et al., 1998). On the cell
surface, KLRG1 exists both as a monomer and as a disulfide-
linked homodimer with interchain disulfides in the stalk region
(Corral et al., 2000). We determined the structure of the CTLD
of mKLRG1 to 1.8 A˚ resolution, as well as the structure of
mKLRG1 bound to hEC1 to 2.0 A˚ resolution (Table 2). We also
determined the structure of the CTLD of hKLRG1 in complex
with hEC1 to 1.7 A˚ resolution.
KLRG1 adopts a fold characteristic of other CTLDs, such as
Ly49 and NKG2D, comprising two a helices (a1 and a2) and
two antiparallel b sheets (Figures 1A and 1B). The two b sheets
are formed by b strands b0, b1, b5, and b10 and by b strands
b20, b2, b4, and b30, respectively. There are three intrachain disul-
fide bonds in the KLRG1 CTLD (Cys75-Cys86, Cys103-Cys184,
and Cys163-Cys176), of which Cys103-Cys184 is invariant in all
CTLDs and Cys163-Cys176 is unique to KLRG1. The structures
of human and mouse KLRG1 are very similar, with a root mean
squared (rms) difference of 1.58 A˚ for 113 a-carbon atoms for
Table 1. Dissociation Constants of KLRG1-Cadherin Interactions
hKLRG1 mKLRG1
hEC1 2.0 3 104 1.3 3 104
hEC1-EC2 1.0 3 104 8.7 3 105
mEC1 1.6 3 104
mEC1-EC2 1.2 3 104
mNC1-NC2; hPC1-PC5 NB 1.3 3 104
Equilibrium dissociation constants (M) were derived from Scatchard
analysis of SPR data (Figure S1). mNC1-NC2, domains 1 and 2 of mouse
N-cadherin. hPC1-hPC5, P-cadherin-Fc chimera. NB, no binding.
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NK Cell Receptor KLRG1 Bound to E-Cadherina comparison of hKLRG1 in the hKLRG1-hEC1 complex with
mKLRG1 in the mKLRG1-hEC1 complex. The main structural
difference between the human and mouse receptors resides in
helix a2, which is shorter in mKLRG1. In addition, the long loop
(L4; residues 144–162) that connects b strands b20 and b3 in
mKLRG1 (Figure 1B) is interrupted by a short b strand (b30) in
hKLRG1 (Figure 1A). Nevertheless, the portion of the L4 loop
that interacts with E-cadherin displays similar conformations in
human and mouse KLRG1 (see below).
All three crystals (mKLRG1, mKLRG1-hEC1, and hKLRG1-
hEC1) contain two KLRG1 molecules or two KLRG1-EC1
Table 2. Data Collection and Refinement Statistics
hKLRG1-hEC1 mKLRG1-hEC1 mKLRG1
Data Collection Statistics
Space group P21 P212121 C2
Unit cell (A˚, ) a = 54.1,
b = 83.4,
c = 56.5,
g = 106.1
a = 53.8,
b = 90.5,
c = 107.6
a = 59.1,
b = 56.9,
c = 68.1,
g = 97.2
Resolution (A˚) 30–1.8 30–2.0 30–1.7
Observations 41,8170 52,0356 78,240
Unique reflections 44,610 36,121 24,208
Completeness (%)a 99.6 (100) 100 (100) 97.7 (94.7)
Mean I/s(I)a 65.3 (6.8) 46.9 (6.2) 10.0 (2.8)
Rsym (%)
a,b 5.8 (38.8) 5.1 (44.1) 5.7 (34.3)
Resolution range (A˚) 30–1.8 30–2.0 30–1.8
Refinement Statistics
Rwork (%)
c 21.4 21.3 22.3
Rfree (%)
c 24.6 25.1 25.7
Protein atoms 3336 3385 1860
Ca2+ 3
Water molecules 309 250 169
Average B values (A˚2)
Protein main chain 27.0 27.9 21.0
Protein side chain 30.1 35.2 25.0
Ca2+ 28.9
Water molecules 34.2 34.3 31.9
Rmsds from ideality
Bond lengths (A˚) 0.0093 0.0098 0.0050
Bond angles () 1.56 1.54 1.25
Ramachandran plot statistics
Most favored (%) 90.3 92.2 91.9
Additionally
allowed (%)
9.2 7.0 7.1
Generously
allowed (%)
0.6 0.3 1.0
Disallowed 0 0 0
a Values in parentheses are statistics for the highest resolution shells.
bRsym =
PjIj  < I > j/
P
Ij, where Ij is the intensity of an individual reflection
and < I > is the average intensity of that reflection.
cRwork =
PjjFoj  jFcjj/
PjFoj, where Fc is the calculated structure factor.
Rfree is as for Rwork but calculated for a randomly selected 5.0% of reflec-
tions not included in the refinement.complexes per asymmetric unit (Table 2). However, the KLRG1
monomers form three totally different dimers in the three crys-
tals. In the mKLRG1-hEC1 complex, the mode of KLRG1 dimer-
ization resembles that of the Ly49C or NKG2D homodimers
(Dam et al., 2003; Li et al., 2001), in which the N termini of the
CTLDs point in the same direction (i.e., toward the NK cell
membrane) and appear in close enough proximity to allow the
stalks to form interchain disulfides (Figures 1C and 1D). There-
fore, the KLRG1 dimer in the mKLRG1-hEC1 structure could
represent a biologically relevant form of the receptor.
The total solvent-accessible surface area buried in the KLRG1
dimer interface is 1272 A˚2, comparable to that in the Ly49C dimer
(1598 A˚2) but less than in NKG2D (2228 A˚2). The interface shows
a relatively low degree of shape complementarity, based on
a calculated shape correlation statistic (Sc) (Lawrence and Col-
man, 1993) of 0.60 (Sc = 1.0 for interfaces with geometrically
perfect fits), which is significantly less than the Sc values for
Figure 1. Structure of KLRG1
(A) Ribbon diagram of human KLRG1, as observed in the hKLRG1-hEC1
complex. Secondary structure elements are labeled. a helices are colored in
green, b strands in yellow, and loops in cyan.
(B) Structure of mouse KLRG1 in unbound form.
(C) Mouse KLRG1 homodimer, as observed in the mKLRG1-hEC1 complex.
(D) Structure of the Ly49C homodimer (Protein Data Bank accession code
3C8J). Secondary structure elements are colored as in (A).Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc. 37
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NK Cell Receptor KLRG1 Bound to E-CadherinLy49C (0.80) and NKG2D (0.69). These factors may explain the
behavior of KLRG1 CTLD (mouse or human) as a monomer in
size exclusion chromatography, and why the putative dimer
was observed in only one of the three crystal structures. By
contrast, Ly49 and NKG2D CTLDs form stable dimers in solution
and in the crystal (Dam et al., 2003; Deng et al., 2008; Li et al.,
2001). Weak association between KLRG1 CTLDs may also
explain the existence of KLRG1 as a mixture of monomers and
dimers on the cell surface (Ortega Soto and Pecht, 1988; Corral
et al., 2000; Rosshart et al., 2008). Nevertheless, interchain disul-
fides within the stalk region of KLRG1 may drive association of
the monomers through the interface observed in the mKLRG1-
hEC1 structure (Figure 1C).
Structure of E-Cadherin
The EC1 domain of E-cadherin, as bound to KLRG1, consists of
eight b strands assembled into two antiparallel b sheets of
strands designated A0BB0ED and CFG, closely related to the Ig
fold (Figures 2A and 2B). The KLRG1 binding site on EC1 partially
overlaps the site that mediates homotypic contacts between
E-cadherin molecules on opposing cells (trans interactions)
that are crucial for cell-cell adhesion (Figure 2C; Nagar et al.,
1996; Pokutta and Weis, 2007; Patel et al., 2003). It also overlaps
the site recognized by the invasion protein internalin from the
bacterium Listeria (Schubert et al., 2002), even though internalin,
a leucine-rich repeat protein, is completely unrelated to KLRG1
(Figure 2D). In both KLRG1-EC1 complexes, the side chain of
EC1 residue Trp2 fills a hydrophobic pocket in the body of the
EC1 domain, as observed in one crystal form of mEC1 (Pertz
et al., 1999) and in hEC1 bound to internalin (Schubert et al.,
2002) (Figure 2E). By contrast, all other cadherin structures
show a strand exchange between neighboring EC1 domains,
placing Trp2 into the corresponding pocket of the second mole-
cule to produce a strand-exchanged dimer that mediates cell
adhesion (Nagar et al., 1996; Patel et al., 2003; Pokutta and
Weis, 2007; Parisini et al., 2007). Hence, KLRG1 binding is
incompatible with cadherin-mediated cell adhesion via the
strand exchange mechanism.
As in the internalin-hEC1 complex (Schubert et al., 2002),
b strands A0 and B0 of hEC1 form a small antiparallel b sheet in
the KLRG1-EC1 complexes (Figure 2F). This b sheet is probably
induced by ligand binding because the segments corresponding
to strands A0 and B0 in KLRG1-bound hEC1 exist as loops in both
monomeric and strand-exchanged EC1 structures (Patel et al.,
2003). In the KLRG1-EC1 complexes, EC1 residues Ile4-Ser8
are extended in a polyproline type II conformation, whereas
they form part of b strand A in all other E-cadherin structures,
including hEC1 bound to internalin (Figure 2F). This unique
conformation is most likely attributable to KLRG1 binding,
because EC1 residues 4–8 contact the receptor (see below).
Overview of the KLRG1-E-Cadherin Complex
The structure of the hKLRG1-hEC1 complex closely resembles
that of the mKLRG1-hEC1 complex (Figure 2B), with rms differ-
ences ranging from 1.46 A˚ to 1.60 A˚ for 196 a-carbon for
comparisons of the two complex molecules in the asymmetric
unit of each crystal. The only notable difference between the
hKLRG1-hEC1 and mKLRG1-hEC1 structures is that residues
11–13 of the loop connecting b strands A0 and B of hEC1 are38 Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc.disordered in hKLRG1-hEC1; however, this part of the loop
does not contact KLRG1 (Figure 2B). By contrast, the entire
A0B loop is well defined in the mKLRG1-hEC1 complex, where
it appears to be stabilized by two bound Ca2+ ions (mKLRG1-
hEC1, but not hKLRG1-hEC1, was crystallized in the presence
of Ca2+). These Ca2+ sites correspond to sites described for
Figure 2. Structure of the KLRG1-EC1 Complex and Comparison
with Other E-Cadherin Complexes
(A) Structure of the mKLRG1-hEC1 complex. Mouse KLRG1 is cyan and hEC1
is purple. The N and C termini of KLRG1 are labeled. Bound Ca2+ ions are
drawn as yellow spheres. Red arrows indicate the BC and FG loops of
hEC1, which bind aEb7 integrin (Taraszka et al., 2000).
(B) Superposition of the mKLRG1-hEC1 and hKLRG1-hEC1 complexes. In the
hKLRG1-hEC1 complex, hKLRG1 is blue and hEC1 is yellow.
(C) Structure of the hEC1-hEC1 strand-swapped adhesion dimer (2O72). The
orientation of the upper hEC1 monomer (purple) is similar to that of hEC1 in (A).
(D) Structure of the Listeria internalin-hEC1 complex (1O6S). The hEC1 domain
(purple) bound to internalin (green) is oriented similarly to hEC1 in (A).
(E) Superposition of hEC1 obtained in complex with KLRG1 (purple), hEC1 ob-
tained in complex with Listeria internalin (yellow) (1O6S), one monomer of
a strand-exchanged hEC1 dimer (cyan) (2O72), and the monomeric form of
mEC1 (green) (1FF5). In monomeric EC1, and in the KLRG1 EC1 and internalin
KLRG1-EC1 complexes, Trp2 occupies an acceptor pocket in the EC1
domain. In the strand-exchanged EC1 dimer, Trp2 forms part of the adhesion
arm that mediates dimerization.
(F) The superposed EC1 structures in (A) are oriented to highlight conforma-
tional differences in the N-terminal region of the domains.
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NK Cell Receptor KLRG1 Bound to E-CadherinFigure 3. Structure-Based Sequence Alignments of KLRG1 Receptors and Cadherins
(A) Sequence alignment of KLRG1 CTLDs. Secondary structure elements for hKLRG1 are denoted by squiggles (a helices) and arrows (b strands). These, and the
loop regions, are numbered according to Figure 1A. Residues that contact E-cadherin in the mKLRG1-hEC1 and hKLRG1-hEC1 complexes are marked with blue
triangles. The paired green numbers (1–3) indicate the bonded cysteine residues in the hKLRG1 and mKLRG1 structures. White characters on a red background
show strictly conserved residues. Residues that are well conserved are drawn in red and framed in blue. The remaining residues are black.
(B) Sequence alignment of the N-terminal domain of classical cadherins. Secondary structure elements for hEC1 are indicated by squiggles (310 helix [h]) and
arrows (b strands). Strands are labeled according to Figure 2A. Residues that contact KLRG1 in the mKLRG1-hEC1 and hKLRG1-hEC1 complexes are denoted
with blue triangles. Sequences were retrieved from SwissProt via the following numbers: hKLRG1, Q96E93; mKLRG1, O88713; rat KLRG1 (rKLRG1) Q64335;
hEC1, P12830; mEC1, P09830; mouse NC1 (mNC1), P15116; mouse RC1 (mRC1), P39038. Sequence alignments were performed with the program ClustalW
(http://www.expasy.ch).human E-cadherin (Figure 2C; Parisini et al., 2007). Further anal-
ysis is based on the mKLRG1-hEC1 structure, unless stated
otherwise.
In the complex, one KLRG1 CTLD binds one EC1 molecule
(Figure 2A; Figure S2A). In this respect, KLRG1 recognition of
its non-MHC ligand is reminiscent of Ly49 recognition of MHC-
I, in which each CTLD monomer contains an entire ligand-binding
site (Figure S2B). By contrast, the binding site of NKG2D for MICA
(Figure S2C; Li et al., 2001), as well as the binding site of NKG2A-
CD94 for HLA-E (Petrie et al., 2008; Kaiser et al., 2008), is formed
by the precise juxtaposition of two CTLD subunits. The KLRG1-
EC1 structure explains our finding that the second Ig-like domain
of E-cadherin (EC2) does not contribute to KLRG1 binding (Table
1), because EC2 makes no contacts with KLRG1 in a model of the
interaction between full-length E-cadherin (EC1–EC5) and
KLRG1 (see Discussion).
E-cadherin docks with its short A0b strand, the N-terminal
portion of the extended peptide segment following the A0 strand,and b strand G onto a surface of KLRG1 that roughly corre-
sponds to the ligand-binding site of other C-type lectin-like
receptors, most notably Ly49s (Dam et al., 2003; Held and Mar-
iuzza, 2008), NKG2D (Li et al., 2001), and NKG2-CD94 (Petrie
et al., 2008; Kaiser et al., 2008). In KLRG1, this site is formed
by three loops (L3, L4, and L6) and b strand 4 (Figures 2A and
3A), whereas the more extensive binding sites of these other
NK receptors comprise additional structural elements of the
CTLD.
The KLRG1-E-Cadherin Interface
The KLRG1-E-cadherin complex buries a total solvent-acces-
sible surface of only 1139 A˚2. By contrast, NK receptors that
recognize MHC or MHC-like ligands bury considerably more
surface: Ly49C-H-2Kb (2393 A˚2) (Deng et al., 2008), NKG2D-
MICA (2374 A˚2) (Li et al., 2001), NKG2A-CD94-HLA-E (1975 A˚2)
(Petrie et al., 2008), LILRB1-HLA-A2 (1783 A˚2) (Willcox et al.,
2003), and KIR2D-HLA-C (1466 A˚2) (Boyington et al., 2000).Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc. 39
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NK Cell Receptor KLRG1 Bound to E-CadherinFigure 4. The Mouse KLRG1-Human E-Cadherin Binding Interface
(A) Stereo view of the mKLRG1-hEC1 interface. The side chains of interacting residues are shown in ball-and-stick representation, with carbon atoms in green
(mKLRG1) or yellow (hEC1), nitrogen atoms in blue, and oxygen atoms in red. Hydrogen bonds are drawn as dotted black lines. In addition to residues 1–108 of
hEC1, an N-terminal methionine residue (M0), introduced by the cloning methodology, is well ordered in the electron density and makes several van der Waals
contacts with mKLRG1.
(B) The mKLRG1 molecular surface is shown in gray with the region contacting hEC1 colored cyan. Residues 1–8 of hEC1 are drawn in stick format and labeled.
(C) The hEC1 molecular surface is shown in gray with the region contacting mKLRG1 colored magenta. Residues 157–161 of mKLRG1 are drawn in stick format
and labeled.Indeed, the exceptionally small interface of the KLRG1-E-cad-
herin complex is at the lower limit of the average value of 1600
(±400) A˚2 for stable protein-protein complexes (Lo Conte et al.,
1999). However, it is similar in size to the interfaces of transient
protein-protein complexes that mediate weak interactions in
intracellular signaling or cell-cell adhesion (Nooren and Thorn-
ton, 2003), such as the adhesion complex between CD2 and
CD58 (1154 A˚2) (Wang et al., 1999).
In the complex, 10 KLRG1 residues interact with nine E-cad-
herin residues, with no bound water molecules or Ca2+ ions in
the interface (Figures 3 and 4A). The interface is characterized
by high shape complementarity, based on an Sc value of 0.77,
which is at the upper end of the range for protein-protein
complexes (Lawrence and Colman, 1993) and greater than the
Sc values of the Ly49C-H-2K
b (0.58) (Deng et al., 2008),
NKG2D-MICA (0.72) (Li et al., 2001), and NKG2A-CD94-HLA-E
(0.59) (Petrie et al., 2008) interfaces. On the hEC1 side of the inter-
face, residues Ile4-Ser8, which adopt a polyproline type II confor-
mation upon interacting with KLRG1 (Figure 2F), form a bulge on
the surface of the ligand that fits snugly into a groove composed40 Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc.of loops L3, L4, and L6, and strand b4 of the receptor (Figure 4B).
Within the groove, hEC1 residue Pro6 is situated in a deep pocket
lined by KLRG1 residues Phe130, Asn157, Gln172, Ala173, and
Ser174, where it makes multiple hydrophobic contacts with
Phe130 and Ser174. On the KLRG1 side of the interface, residues
Asn157-Gln161 of loop L4 lie in a long groove formed by the Ile4-
Ser8 segment of hEC1 and by strands A0 and G (Figure 4C). The
mainly hydrophobic KLRG1-hEC1 interface contains nine
hydrogen bonds (Figure 4A; Table S1), which is considerably
more than expected based on the size of the interface (Wodak
and Janin, 2003). All these hydrogen bonds are strictly conserved
in the hKLRG1-hEC1 and mKLRG1-hEC1 complexes and all are
between main-chain atoms of hEC1 and main-chain or side-
chain atoms of KLRG1 (Table S1). The high shape complemen-
tarity of the KLRG1-hEC1 interface, the complete exclusion of
bulk solvent, and the relative abundance of intermolecular
hydrogen bonds probably compensate for the small size of the
interface to achieve sufficient affinity for inhibitory signaling.
In addition to KLRG1, lymphocytes express another receptor
for E-cadherin, the integrin aEb7 (CD103), which mediates
Immunity
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Although no structure is available for E-cadherin bound to aEb7
integrin, mutational analysis of hEC1 has localized the binding
site to the face formed by loops BC and FG (Taraszka et al.,
2000), which is distinct from the KLRG1 binding site on E-cad-
herin (Figure 3A). The aEb7 integrin binding site is also distinct
from the site that mediates trans interactions between E-cad-
herin molecules during cell-cell adhesion.
Functional Validation and Mutational Analysis
of the KLRG1-E-Cadherin Interface
To functionally validate the KLRG1-E-cadherin interface ob-
served in the crystal structures, as well as to identify key binding
interactions, we prepared a panel of six alanine-substituted
mutants of human KLRG1. The residues chosen (Phe130,
Figure 5. Mutational Analysis of the KLRG1-
E-Cadherin Interface
(A) A5-KLRG1 reporter cells carrying the indicated
alanine substitutions in the extracellular domain of
human KLRG1 were cultured in plates precoated
with different concentrations of KLRG1 mAb
(black lines) or E-cadherin-Fc chimera (red lines).
Cells were harvested after 17 hr and induction of
GFP expression was determined by flow cytome-
try. Dots represent values from individual assays
and data from at least three independent experi-
ments are shown.
(B) A5-KLRG1 reporter cells were cocultured with
parental (black bars) or E-cadherin-transduced
(gray bars) K562 cells. GFP expression was deter-
mined after 17 hr. Results are shown as mean
values including SEM derived from three indepen-
dent experiments.
Asn157, Ser158, Gln161, Gln172, and
Ser175) are involved in hydrogen bonding
and/or van der Waals contacts with hEC1
(Table S1). The reactivity of the KLRG1
mutants was determined in a reporter
cell assay with A5 T cell hybridomas ex-
pressing the extracellular domain of
KLRG1 fused to the intracellular domain
of CD3z. Engagement of the chimeric
KLRG1 receptor in this system results in
green fluorescent protein (GFP) expres-
sion as shown by the fact that A5 cells
contain a NFAT-driven GFP-expression-
cassette (Schwartzkopff et al., 2007;
Andersen et al., 2001). Cell surface
expression of the mutant KLRG1-CD3z
chimeras after retroviral transduction
was verified by staining with different
monoclonal antibodies (mAb) specific for
human KLRG1 (Figure S3). Importantly,
engagement of mutant KLRG1-CD3z
chimeras by plate-bound KLRG1 mAb re-
sulted in a robust and dose-dependent
GFP induction in all cell lines (Figure 5A,
black lines). The reactivity of the KLRG1-
CD3z mutant molecules toward E-cadherin were then assayed
via plate-bound E-cadherin-Fc chimeras (Figure 5A, red lines).
The results revealed that alanine substitution of KLRG1 residues
Gln161 and Ser175 completely abrogated the ability to trigger
a response. GFP induction in alanine mutants of Phe130 and
Asn157 was also strongly reduced, although some residual
activity could be detected at high concentrations of E-cadherin-
Fc chimeras. However, mutation of Ser158 or Gln172 did not
reduce the reactivity of A5-KLRG1 reporter cells toward E-cad-
herin. This lack of effect may be explained by the location of
Ser158 and Gln172 at the periphery, rather than center, of the
protein-protein interface (Figure 4A), where solvent rearrange-
ments are known to compensate for mutations (Sundberg and
Mariuzza, 2003). In rat KLRG1, Gln172 is replaced by histidine
(Figure 3A). This reactivity pattern was confirmed for all sixImmunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc. 41
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E-cadherin (Figure 5B). These results identify Phe130, Asn157,
Gln161, and Ser175 as crucial residues for KLRG1 recognition
of E-cadherin and validate the KLRG1-E-cadherin interface
observed in the crystal.
Basis for Binding Specificity
KLRG1 recognized E-, N-, and R-cadherin in the reporter cell
assay, but showed no reactivity toward M-, P-, or VE-cadherin
(Figure S4), in agreement with functional studies (Ito et al.,
2006; Tessmer et al., 2007). The ability of KLRG1 to recognize
three classical cadherins (E-, N-, and R-) is readily explained
by the KLRG1-hEC1 structure. Thus, hEC1 residues Val3-Ile7,
which account for most of the interactions with KLRG1 (54 of
74 van der Waals contacts; six of nine hydrogen bonds), are
absolutely conserved in N- and R-cadherins (Figure 3B).
Although the other KLRG1-contacting region, comprising resi-
dues 92–95, is variable in E-, N-, and R-cadherins, two of these
residues are conservatively substituted (Glu-Asp93 and Ile-
Leu94). Moreover, all three hydrogen bonds between KLRG1
and hEC1 residues 92–95 involve main-chain, rather than side-
chain, atoms of the ligand (Table S1). Such interactions should
facilitate the accommodation of diverse amino acids at these
KLRG1-contacting positions.
The KLRG1-hEC1 structure also explains the inability of
KLRG1 to bind two other classical cadherins, M- and P-cadherin
(Ito et al., 2006). In P-cadherin, Ile4 of hEC1 is replaced by valine,
whose side chain would be too short to contact Gln161 of
KLRG1, a crucial residue for E-cadherin recognition (Figure 5).
In addition, P-cadherin contains alanine, rather than proline, at
position 5, which could alter the main-chain conformation at
this site, thereby disrupting interactions with KLRG1 residues
Asn157, Gln161, and Ser174 (Table S1). In the KLRG1-hEC1
complex, Met92 of hEC1 makes multiple hydrophobic contacts,
through its side chain, with Ser158, Phe159, and Val160 of
KLRG1 (Figure 4A). These interactions would be lost upon
replacement of Met92 by threonine in M-cadherin.
DISCUSSION
Antigen-specific receptors involved in adaptive immunity,
notably antibodies and T cell receptors (TCRs), are both highly
diverse and highly discriminatory. By contrast, MHC-specific
NK receptors involved in missing self recognition, including
Ly49s and the KIRs, show limited diversity and are only moder-
ately discriminatory (Yokoyama and Plougastel, 2003; Lanier,
2005). Thus, individual Ly49s recognize multiple H-2D and
H-2K alleles, independently of the bound peptide, by engaging
MHC-I at a site underneath the peptide-binding platform formed
by b2-microglobulin and mainly nonpolymorphic residues of the
MHC-I heavy chain (Deng and Mariuzza, 2006). KIR receptors,
whose docking mode onto MHC-I resembles that of TCRs,
bind multiple HLA-A, -B, and -C alleles by contacting mostly
invariant residues of the a1 and a2 helices while minimizing inter-
actions with the bound peptide (Boyington et al., 2000; Fan et al.,
2001). Similarly, KLRG1 recognizes three of seven classical cad-
herins (E-, N-, and R-) by binding to a highly conserved site on
these self ligands, including a nearly invariant motif (VIPPI; resi-
dues 3–7) in their N-terminal Ig-like domain. However, just as42 Immunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc.individual Ly49 and KIR receptors display a degree of MHC
allelic specificity (Yokoyama and Plougastel, 2003; Lanier,
2005), KLRG1 discriminates among classical cadherins through
additional interactions involving a considerably more variable
region of these molecules (M,I,T,V-E,N,D,P-I,L-T,L,S,V,Y,E; resi-
dues 92–95). In this way, NK cells bearing a single KLRG1
receptor can monitor expression of several cadherins on target
cells, resulting in MHC-independent missing self recognition.
The interaction of KLRG1 with cadherins shows parallels but
also differences to the 2B4-CD48 receptor-ligand system with
regard to the regulation of NK cell function by non-MHC ligands.
In humans, 2B4 acts mainly as an activating receptor, whereas in
mice it is inhibitory (McNerney et al., 2005a). In distinction,
KLRG1 functions as an inhibitory receptor in both species. The
inhibitory function of mouse 2B4 has been shown in various
assay systems in vitro. Moreover, 2B4-mediated inhibition of
CD48+ tumor cell clearance and protection of bone marrow cells
from NK cell attack in the absence of self-MHC-I has been
demonstrated in vivo (Lee et al., 2004; McNerney et al.,
2005b). In the KLRG1-E-cadherin system, analogous in vivo
data are not available, but KLRG1-mediated inhibition of NK
and T cell function has been demonstrated (Robbins et al.,
2002; Gru¨ndemann et al., 2006; Ito et al., 2006). Missing self
recognition should involve a ligand that is downregulated during
a disease process and we are not aware of any data suggesting
that malignant or infected cells downregulate CD48 to escape
NK cell control. By contrast, the importance of E-cadherin down-
regulation during tumor progression and its role as a tumor
suppressor are very well established (Jeanes et al., 2008).
However, direct in vivo data about the functional role the
KLRG1-E-cadherin interaction are missing, because KLRG1-
deficient mice have not yet been published.
E-cadherin function is often abrogated during development of
human carcinomas (Takeichi, 1993; Cowin et al., 2005; Jeanes
et al., 2008). For example, somatic mutations of the E-cadherin
gene are found in 50% of diffuse-type gastric carcinomas.
Most of the observed gene alterations are splice-site mutations
resulting in in-frame loss of exon 8 or 9 and produce deletions
in EC2 or EC3 (Becker et al., 1994). These tumor-associated
mutations interfere with binding to KLRG1 and lower the
threshold for NK cell triggering (Schwartzkopff et al., 2007).
Because we have shown that KLRG1 recognizes E-cadherin
through EC1, with no direct involvement of EC2-EC5, deletions
in EC2 or EC3 may indirectly alter the conformation of the
KLRG1-binding site of EC1 or disrupt the overall structure of
the cadherin ectodomain, whose integrity depends on Ca2+
ions at the interfaces between individual Ig-like domains (Po-
kutta and Weis, 2007).
The affinity of KLRG1 for cadherins (KD150 mM) is much
stronger than the affinity between cadherin monomers in adhe-
sion dimers (700 mM) (Ha¨ussinger et al., 2004). However, it is
considerably weaker than for any other NK receptor-ligand pair
characterized to date (see Results). We propose that KLRG1
compensates for its exceptionally low monomeric affinity for
cadherins through multipoint attachment to cadherin molecules
on the target cell surface. In addition to trans interactions
between cadherin molecules on opposing cells, cadherins
emanating from the same cell membrane are believed to form
lateral (cis) interactions (Figure S5A; Pokutta and Weis, 2007).
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2002), EC1 of one molecule contacts EC2 of another; this cis
interaction is also present in several two-domain structures of
E-cadherin (Pokutta and Weis, 2007). Based on the KLRG1-
hEC1 structure, cadherin molecules that are not engaged in trans
should be available to bind KLRG1 receptors on the NK cell. A
model of KLRG1-cadherin interactions at the NK cell-target
cell interface may be constructed by superposing the KLRG1-
hEC1 complex onto cadherin molecules arrayed in parallel on
the target cell surface via cis interactions (Figure S5B). In this
way, KLRG1-cadherin recognition could be achieved through
the cooperativity of multiple associations, rather than by relying
on the stability of individual complexes, while still allowing for
dissociation of the complexes during transient NK cell-target
cell encounters. Additionally, the ability of KLGR1 to form disul-
fide-linked dimers (Corral et al., 2000), or even multimers (Ros-
shart et al., 2008), may further increase the avidity of KLRG1-
cadherin interactions through multivalent binding.
Besides NK cells, KLRG1 is expressed on subsets of T
lymphocytes (Voehringer et al., 2001), where it has been used
to discriminate short-lived effector T cells from long-lived
memory cell precursors (Joshi et al., 2008). Certain T lympho-
cytes also express aEb7 integrin, which mediates T cell homing
and adhesion to epithelial cells via interactions with E-cadherin
(Agace et al., 2000). These T cells provide immunosurveillance
against infected, damaged, or transformed epithelial cells.
Recently, the interaction of aEb7 integrin on tumor-infiltrating
lymphocytes with E-cadherin on ICAM-1-negative tumor cells
was shown to promote cytotoxic T lymphocyte activity by trig-
gering lytic granule polarization and exocytosis (Le Floc’h
et al., 2007). Because of their advanced differentiation as
effector T cells, tumor-infiltrating lymphocytes probably also
express KLRG1. If so, KLRG1 would compete with aEb7 integrin
for binding to E-cadherin, resulting in transmission of opposite
signals to the T cell. Apart from competition, however, the possi-
bility also exists of coengagement of KLRG1 and aEb7 integrin by
a single E-cadherin molecule (Colonna, 2006). Indeed, the
KLRG1-hEC1 structure reported here, together with mutational
studies of the aEb7-E-cadherin interaction (Taraszka et al.,
2000), indicate that KLRG1 and aEb7 recognize distinct sites on
E-cadherin, such that binding of one receptor may not preclude
binding of the other. Such coengagement may allow cross-talk
between KLRG1 and aEb7, whereby KLRG1 inhibits activation
of aEb7 integrin, thus modulating its control over lymphocyte
migration and function.
EXPERIMENTAL PROCEDURES
Protein Preparation
The C-type lectin-like domains of mouse (residues Cys75-Tyr189) and human
(residues Cys75-Lys186) KLRG1 were cloned into the expression vector pET-
26b (Novagen) and expressed as inclusion bodies in BL21(DE3) Escherichia
coli cells (Novagen). The inclusion bodies were washed with 50 mM Tris-HCl
(pH 8.0) containing 5% (v/v) Triton X-100, then dissolved in 6 M guanidine,
50 mM Tris-HCl (pH 8.0), and 10 mM DTT. For in vitro folding, the inclusion
bodies were diluted into ice-cold folding buffer containing 0.4 M L-arginine-
HCl, 50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 3 mM reduced glutathione, and
0.9 mM oxidized glutathione to a final protein concentration of 40 mg/l. After
72 hr at 4C, folded proteins were separated from aggregates via a Superdex
S-75 column (GE Healthcare). Further purification was carried out by MonoS
(mKLRG1) or MonoQ (hKLRG1) chromatography.For production of biotinylated mouse and human KLRG1, a 16-amino acid
tag (GSLNDIFEAQKIEWHE) was added to the N termini of both receptors.
The tagged proteins were produced in the same way as the unmodified
proteins. Biotinylation was performed with a Biotinylation Kit (Avidity); biotiny-
lated KLRG1 was separated from excess biotin with a Superdex S-75 column.
The first N-terminal domain of mouse and human E-cadherin (mEC1 and
hEC1; residues Asp1-Phe108), the first and second N-terminal domains of
mouse and human E-cadherin (mEC1-EC2 and hEC1-EC2; residues Asp1-
Phe221), and the first and second N-terminal domains of mouse N-cadherin
(mNC1-NC2; residues Asp1-Phe223) were cloned into pET-26b. Both mEC1
and mEC1-EC2 were expressed as soluble proteins in E. coli BL21(DE3) cells.
The protein were purified from cell lysates with a POROS 20 HQ column
(Applied Biosystems), followed by sequential Superdex S-75 and MonoQ
columns. By contrast, hEC1, hEC1-EC2, and mNC1-NC2 were expressed in
inclusion bodies. After solubilization in 4 M urea, the inclusion bodies were dia-
lyzed overnight at 4C against 50 mM Tris-HCl (pH 8.0). Folded proteins were
purified with Superdex S-75 and MonoQ columns.
Crystallization and Data Collection
Crystals of unbound mKLRG1 (4 mg/ml) were grown in hanging drops at room
temperature in 0.7 M Na/KPO4 and 0.1 M HEPES (pH 8.0). For crystallization of
KLRG1-cadherin complexes, hKLRG1 or mKLRG1 was mixed with hEC1 in a
1:1 molar ratio to a final protein concentration of 10 mg/ml. The hKLGR1-
hEC1 complex crystallized in 25% (w/v) polyethylene glycol monomethyl ether
4000, 200 mM ammonium acetate, and 100 mM sodium acetate (pH 4.6). The
mKLRG1-hEC1 complex crystallized in 18% (w/v) polyethelene glycol 8000,
200 mM calcium acetate, and 100 mM sodium cacodylate (pH 6.5).
For data collection, hKLGR1-hEC1 crystals were transferred to a cryoprotec-
tant solution of mother liquor containing 30% (w/v) PEG 4000, prior to flash
cooling in liquid nitrogen. X-ray diffraction data were collected to 1.8 A˚ resolu-
tion at beamline X29 of the Brookhaven National Synchrotron Light Source
(BNSLS). Crystals of unbound mKLRG1 and mKLRG1-hEC1 were cryopro-
tected by soaking in mother liquor containing 20% (v/v) glycerol. For mKLRG1,
diffraction data to 1.7 A˚ resolution were measured on a Rigaku R-axis IV2+
image plate detector with CuKa radiation from a Micromax-007 rotating anode
generator. For the mKLRG1-hEC1 complex, diffraction data to 2.0 A˚ resolution
were recorded at BNSLS. All data were indexed, integrated, and scaled with
the program CrystalClear 1.3.6 (Rigaku) or HKL2000 (Otwinowski and Minor,
1997). Data collection statistics are summarized in Table 2.
Structure Determination and Refinement
The structures of mKLRG1, hKLRG1-hEC1, and mKLRG1-hEC1 were solved
by molecular replacement with Phaser (Storoni et al., 2004). A search of the
mKLRG1 sequence against the Protein Data Bank showed that mKLRG1 is
most similar to human CD94 (PDB accession code 1B6E) (Boyington et al.,
1999) and human CD69 (1FM5) (Natarajan et al., 2000), with 33% and 24%
sequence identity, respectively. However, no molecular replacement solution
was found with CD94 or CD69 alone. Phaser was then used to build an
ensemble model by combining the aligned CD94 and CD69 structures. With
this ensemble search model, the two mKLRG1 molecules were located by
automatic rotation and translation searches with Z-score of 7.4; initial rigid
body refinement gave Rfree of 39.1% and Rwork of 38.0%. The partially refined
mKLRG1 structure and a human E-cadherin domains 1 and 2 structure (2O72)
(Parisini et al., 2007) were used as search models for solving the structures of
hKLRG1-hEC1 and mKLRG1-hEC1. The two KLRG1 and two EC1 molecules
in the asymmetric unit of both crystals were located by rotation and translation
searches with Z-scores of 18.3 and 27.0 for the hKLRG1-hEC1 and mKLRG1-
hEC1 complexes, respectively. All refinements were carried out with CNS1.1
(Bru¨nger et al., 1998), including iterative cycles of simulated annealing, posi-
tional refinement, and B factor refinement, interspersed with model rebuilding
into sA-weighted Fo Fc and 2Fo Fc electron density maps via XtalView
(McRee, 1999). Refinement statistics are summarized in Table 2. Stereochem-
ical parameters were evaluated with PROCHECK (Laskowski et al., 1993).
SPR Analysis
The interaction of KLRG1 with E- and N-cadherins was assessed by SPR with
a BIAcore T100 biosensor. Typically, biotin-KLRG1 was immobilized on the
sensor chip by flowing a biotin-KLRG1 solution (20 mg/ml) containing 0.5 MImmunity 31, 35–46, July 17, 2009 ª2009 Elsevier Inc. 43
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density. After immobilizing 200–500 resonance units (RU), 20 ml of a 20 mM
biotin solution was injected to block the remaining streptavidin sites. As the
blank, biotin alone was injected. Immediately prior to SPR analysis, all cad-
herin preparations were purified with a Superdex S-75 column to eliminate
possible aggregates. To assess cadherin binding, solutions containing
different concentrations of cadherin were injected sequentially over flow cells
immobilized with KLRG1. The data were analyzed with BIAevaluation 4.1 soft-
ware. Dissociation constants (KDs) were determined from Scatchard analysis,
after correction for nonspecific binding, by measuring the concentration of free
reactants and complex at equilibrium. Standard deviations for two or more
independent KD determinations were typically <20%.
Construction of Mutated KLRG1-CD3z Chimeras
The generation of a cDNA encoding the transmembrane and extracellular
domain of human KLRG1 fused to the cytoplasmic domain of mouse CD3z
has been described previously (Schwartzkopff et al., 2007). The KLRG1-
CD3z cDNA cloned in the XhoI site of pcDNA3.1/Zeo (Invitrogen) was used
as a template DNA for site-directed mutagenesis. The mutants were con-
structed by Quick-Change site-directed mutagenesis via PfuTurbo DNA poly-
merase (Stratagene). PCR products were digested with DpnI and transformed
into Top10 competent cells (Invitrogen). The mutations were confirmed by
sequencing the pcDNA3.1-KLRG1-CD3z clones and sequence-verified XhoI/
NotI fragments were subcloned in the pMSCV2.2 proviral vector. Retroviral
transduction of A5 T cell hybridoma cells was performed as described
(Schwartzkopff et al., 2007) and KLRG1-expressing cells were enriched by
magnetic beads (Miltenyi Biotec).
Reporter Cell Assay
Assays with plate-bound stimulation were performed in 96-well high-binding
polystyrene flat-bottom EIA/RIA plates (Corning) precoated overnight at 4C
with the indicated concentration of anti-KLRG1 mAb (clone 13F12F2, 13A2,
or 1A12) (Voehringer et al., 2001; Marcolino et al., 2004) or recombinant fusion
proteins consisting of all five extracellular domains of human E-cadherin fused
to the Fc portion of human IgG1 (RD Systems). After washing with PBS, A5-
KLRG1 reporter cells (5 3 104 in 100 ml culture medium/well) were added
and cultured for 17 hr before flow cytometric analysis. In cell-based assays,
105 A5-KLRG1 reporter cells (105/well) were cocultured with parental or E-cad-
herin-transduced K562 cells (105/well) in 1 ml culture medium in 24-well plates
for 17 hr. Afterwards, cells were harvested, stained with anti-mouse CD4 mAb
(e-Bioscience) to distinguish A5 reporter cells from K562 cells, and analyzed
for GFP expression by flow cytometry.
Accession Codes
Atomic coordinates and structure factors have been deposited in the Protein
Data Bank: mKLRG1, 3FF9; hKLRG1-hEC1, 3FF7; and mKLRG1-hEC1, 3FF8.
SUPPLEMENTAL DATA
Supplemental Data include five figures and one table and can be found with
this article online at http://www.cell.com/immunity/supplemental/S1074-
7613(09)00276-3.
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